# Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection

> **NCT00709605** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 31 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** VRC-HIVADV014-00-VP

## Key facts

- **NCT ID:** NCT00709605
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06-25
- **Primary completion:** 2014-05-20
- **Final completion:** 2014-05-20
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00709605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00709605, "Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00709605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*